RECRUITING

Clinical Procedures to Support Research in ALS

Talk to us

Conditions

Amyotrophic Lateral SclerosisALS-Frontotemporal DementiaPrimary Lateral SclerosisProgressive Muscular Atrophy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

Official Title

Clinical Procedures to Support Research in ALS (CAPTURE-ALS)

Quick Facts

Study Start:2018-02-15
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03489278

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of ALS or a related disorder (e.g. primary lateral sclerosis, progressive muscular atrophy).
  2. * Receiving care at a clinical center that uses Epic as its EHR.
  3. * Able and willing to provide informed consent (or informed consent obtainable from a designated proxy).
  1. * Inability to understand English and/or Spanish

Contacts and Locations

Study Contact

Michael Benatar, MBChB, MS, DPhil
CONTACT
1-844-837-1031
projectcreate@miami.edu
Anne-Laure Grignon
CONTACT
1-844-837-1031
projectcreate@miami.edu

Principal Investigator

Michael Benatar, MBChB, MS, DPhil
PRINCIPAL_INVESTIGATOR
University of Miami

Study Locations (Sites)

University of California, Irvine
Irvine, California, 92868
United States
Stanford University
Palo Alto, California, 94304
United States
California Pacific Medical Center
San Francisco, California, 94115
United States
University of Miami
Miami, Florida, 33136
United States
University of Kansas Medical Center
Kansas City, Kansas, 66205
United States
Hennepin County Medical Center
Minneapolis, Minnesota, 55404
United States
Columbia University
New York, New York, 10032
United States
Duke University
Durham, North Carolina, 27708
United States
Wake Forest University
Winston-Salem, North Carolina, 27157
United States
Providence Health & Services
Portland, Oregon, 97213
United States
University of Texas San Antonio Health Science Center
San Antonio, Texas, 78229
United States

Collaborators and Investigators

Sponsor: University of Miami

  • Michael Benatar, MBChB, MS, DPhil, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-02-15
Study Completion Date2025-06

Study Record Updates

Study Start Date2018-02-15
Study Completion Date2025-06

Terms related to this study

Additional Relevant MeSH Terms

  • Amyotrophic Lateral Sclerosis
  • ALS-Frontotemporal Dementia
  • Primary Lateral Sclerosis
  • Progressive Muscular Atrophy